Associated Papers
Novel microsatellite instability test of sebaceous tumours to facilitate low-cost universal screening for Lynch syndrome.
Gallon R et al.
Clinical and Experimental Dermatology, 2025
39847610 (PubMed )
Supplement: llaf005_supplementary_data.zip › Supplementary_Appendices.pdf
Risk of lymphoid malignancy associated with cancer predisposition genes.
Boddicker NJ et al.
Blood Cancer Journal, 2025
40253392 (PubMed )
Supplement: 41408_2025_1283_MOESM1_ESM.xlsx › Table_S15
Assessing the genomic feature of Chinese patients with ampullary adenocarcinoma: potential therapeutic targets.
Dong Z et al.
Bmc Cancer, 2024
Phase separation as a possible mechanism for dosage sensitivity.
Yang L et al.
Genome Biology, 2024
38225666 (PubMed )
Supplement: 13059_2023_3128_MOESM3_ESM.xlsx › NMD-escaping_mutations
Interval between the First Cancer and the Genetic Diagnosis in Lynch Syndrome Probands.
Yamashita K et al.
Internal Medicine (tokyo, Japan), 2021
Lynch syndrome mutation spectrum in New South Wales, Australia, including 55 novel mutations.
Sjursen W et al.
Molecular Genetics & Genomic Medicine, 2016
Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic.
Foley SB et al.
Ebiomedicine, 2015
26023681 (PubMed )
Supplement: mmc1.pdf
Select a paper to view details